Home
Conditions
Immune Checkpoint Inhibitors

Clinical trial condition

Immune Checkpoint Inhibitors

Explore clinical trials studying Immune Checkpoint Inhibitors. Study availability and eligibility vary by location and protocol.

29 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Immune Checkpoint Inhibitors trial results

Active, not recruiting

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

NCT06124378

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +10 more
Locations: The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Active, not recruiting

HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC

NCT06632106

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: The first hospital of China medical university Shenyang, Liaoning, China

View Trial Details

Active, not recruiting

Relationship Between Immunity and Metabolism in Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer. ( RIMEC )

NCT04808817

Conditions: Cancer, Immune Checkpoint Inhibitors, Metabolic Diseases, +3 more
Locations: Hôpital Cochin Paris, Île-de-France Region, France

AP-HP - Hôpital Européen Georges-Pompidou Paris Paris, Île-de-France Region, France

View Trial Details

Completed

COVICI-SURV: COVID-19 Vaccination Around ICI Start and Survival

NCT07729241

Conditions: COVID-19, COVID-19 Vaccination, Cancer, +14 more
Locations: Hôpital Pitié Salpêtrière / CIC-2503, Paris Paris, France

View Trial Details

Completed

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

NCT03948724

Conditions: Adenocarcinoma, Advanced Non-Small Cell Lung Cancer, Carcinoma, +29 more
Locations: Chu Angers Angers, France

Institut de Cancerologie de L'Ouest Angers, France

Centre Francois Baclesse Caen, France

Centre D'Oncologie Et de Radiotherapie 37 Chambray-lès-Tours, France

View Trial Details

Completed

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

NCT04670445

Conditions: Adenocarcinoma, Adenoma, Advanced Lung Cancer, +94 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients

NCT07631611

Conditions: Brain Diseases, Brain Metastasis, Brain Neoplasms, +13 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients

NCT06629714

Conditions: Biomarkers / Blood, Bronchial Neoplasms, Cancer, Treatment-Related, +18 more
Locations: Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

View Trial Details

Completed

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

NCT05273255

Conditions: Cancer, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors, +2 more
Locations: University of Zurich, University Hospital Zurich Zurich, Switzerland

View Trial Details

Immune Checkpoint Inhibitors

Immune Checkpoint Inhibitors trial results

Related conditions